{"id":26540,"date":"2026-04-28T08:59:26","date_gmt":"2026-04-28T06:59:26","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/"},"modified":"2026-05-05T17:14:36","modified_gmt":"2026-05-05T15:14:36","slug":"farmaci-in-italia-la-geografia-della-domanda-sanitaria","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/","title":{"rendered":"Medicines in Italy: the geography of Healthcare demand"},"content":{"rendered":"<p>The most up-to-date snapshot of medicine use in Italy comes from the <a href=\"https:\/\/www.aifa.gov.it\/-\/uso-farmaci-online-rapporti-regionali-2024\" target=\"_blank\" rel=\"noopener\">2024 Regional Reports<\/a> published by <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Agenzia Italiana del Farmaco<\/span><\/span> (AIFA). These reports analyse consumption and expenditure at a territorial level and currently represent the most accurate reference for understanding regional dynamics.<\/p>\n<p data-start=\"413\" data-end=\"614\">This is not merely a statistical update, but a lens through which to observe how the Italian pharmaceutical system actually works: not as a uniform structure, but as the <strong>sum of diverse regional models<\/strong>.<\/p>\n<h2 data-start=\"103\" data-end=\"151\">Stable consumption, shifting therapeutic mix<\/h2>\n<p data-start=\"153\" data-end=\"322\">The first key finding is the stability of consumption. Italy remains at consolidated levels, with around 1.9 defined daily doses per capita, in line with previous years.<\/p>\n<p data-start=\"324\" data-end=\"427\">However, this stability can be misleading.<br data-start=\"366\" data-end=\"369\" \/><strong>The mix of medicines being used is changing significantly.<\/strong><\/p>\n<p data-start=\"429\" data-end=\"521\">What is increasing is not volume, but the weight of high-complexity therapies, particularly:<\/p>\n<ul data-start=\"523\" data-end=\"600\">\n<li data-section-id=\"1u9nepb\" data-start=\"523\" data-end=\"541\">oncology drugs<\/li>\n<li data-section-id=\"16jgahd\" data-start=\"542\" data-end=\"562\">immunomodulators<\/li>\n<li data-section-id=\"1w0qriu\" data-start=\"563\" data-end=\"600\">treatments for chronic conditions<\/li>\n<\/ul>\n<p data-start=\"602\" data-end=\"713\">The result is a system with broadly unchanged consumption levels, but a more sophisticated therapeutic profile.<\/p>\n<h2 data-start=\"128\" data-end=\"179\">Spending is rising, but not due to inefficiency<\/h2>\n<p data-start=\"181\" data-end=\"349\">According to the latest available data (<a href=\"https:\/\/www.aifa.gov.it\/-\/rapporto-osmed-2024-uso-farmaci-italia\" target=\"_blank\" rel=\"noopener\">OsMed Report<\/a>), total pharmaceutical expenditure has exceeded \u20ac37 billion, showing moderate growth compared to the previous year.<\/p>\n<p data-start=\"351\" data-end=\"483\">This trend is not driven by an indiscriminate increase in prescriptions.<br data-start=\"423\" data-end=\"426\" \/>Rather, it reflects the combined effect of three factors:<\/p>\n<ul data-start=\"485\" data-end=\"683\">\n<li data-section-id=\"14x7a3u\" data-start=\"485\" data-end=\"539\">the introduction of high-cost innovative therapies<\/li>\n<li data-section-id=\"veewz4\" data-start=\"540\" data-end=\"615\">the growing burden of chronic conditions linked to an ageing population<\/li>\n<li data-section-id=\"1ogf17o\" data-start=\"616\" data-end=\"683\">a broader level of care provided by the National Health Service<\/li>\n<\/ul>\n<p data-start=\"685\" data-end=\"778\">The system, therefore, is not out of control.<br data-start=\"730\" data-end=\"733\" \/>It is undergoing a structural transformation.<\/p>\n<h2 data-start=\"785\" data-end=\"841\">Regional variability remains the most critical issue<\/h2>\n<p data-start=\"843\" data-end=\"899\">This is precisely where the AIFA Reports become crucial.<\/p>\n<p data-start=\"901\" data-end=\"959\">Differences across regions remain significant and concern:<\/p>\n<ul data-start=\"961\" data-end=\"1084\">\n<li data-section-id=\"1g0anup\" data-start=\"961\" data-end=\"986\">levels of consumption<\/li>\n<li data-section-id=\"153zugs\" data-start=\"987\" data-end=\"1013\">per capita expenditure<\/li>\n<li data-section-id=\"1dc2e3u\" data-start=\"1014\" data-end=\"1045\">prescribing appropriateness<\/li>\n<li data-section-id=\"ol5wjk\" data-start=\"1046\" data-end=\"1084\">uptake of generics and biosimilars<\/li>\n<\/ul>\n<p data-start=\"1086\" data-end=\"1308\">In some areas of the country, a more efficient use of resources can be observed, with wider adoption of generic medicines. In others, higher consumption levels persist, along with a greater share of out-of-pocket spending.<\/p>\n<p data-start=\"1310\" data-end=\"1437\">This is not a new issue, but it remains unresolved.<br data-start=\"1361\" data-end=\"1364\" \/>And it continues to represent one of the system\u2019s main points of tension.<\/p>\n<h2 data-start=\"1444\" data-end=\"1492\">Public and private, a balance being reshaped<\/h2>\n<p data-start=\"1494\" data-end=\"1650\">In 2024, around 70% of pharmaceutical expenditure is covered by the National Health Service, while more than \u20ac10 billion remains directly borne by citizens.<\/p>\n<p data-start=\"1652\" data-end=\"1744\">This is not simply a rise in private spending.<br data-start=\"1698\" data-end=\"1701\" \/>It is a redistribution of responsibilities:<\/p>\n<ul data-start=\"1746\" data-end=\"1876\">\n<li data-section-id=\"1d2oztq\" data-start=\"1746\" data-end=\"1810\">the public sector focuses on high-value, high-cost therapies<\/li>\n<li data-section-id=\"1k6qhgy\" data-start=\"1811\" data-end=\"1876\">citizens bear an increasing share of non-reimbursed medicines<\/li>\n<\/ul>\n<p data-start=\"1878\" data-end=\"1989\">While this model improves overall system sustainability, it also raises important questions in terms of equity.<\/p>\n<h2 data-start=\"81\" data-end=\"122\">Appropriateness, the unresolved issue<\/h2>\n<p data-start=\"124\" data-end=\"231\">If volumes remain stable and spending grows in a controlled manner, the real issue becomes appropriateness.<\/p>\n<p data-start=\"233\" data-end=\"258\">Regional data still show:<\/p>\n<ul data-start=\"260\" data-end=\"433\">\n<li data-section-id=\"u7yh52\" data-start=\"260\" data-end=\"317\">prescribing differences that are not always justified<\/li>\n<li data-section-id=\"119sbe6\" data-start=\"318\" data-end=\"361\">uneven levels of adherence to therapies<\/li>\n<li data-section-id=\"1qqjbgg\" data-start=\"362\" data-end=\"433\">variability in the use of certain drug classes, such as antibiotics<\/li>\n<\/ul>\n<p data-start=\"435\" data-end=\"562\">In this context, medicines become an indicator of the overall quality of the healthcare system, rather than simply a cost item.<\/p>\n<h2 data-start=\"84\" data-end=\"134\">A system under control, but not yet integrated<\/h2>\n<p data-start=\"136\" data-end=\"209\">Overall, the picture that emerges is less critical than one might expect.<\/p>\n<p data-start=\"211\" data-end=\"245\">The Italian pharmaceutical system:<\/p>\n<ul data-start=\"247\" data-end=\"329\">\n<li data-section-id=\"1jpfe16\" data-start=\"247\" data-end=\"282\">keeps consumption under control<\/li>\n<li data-section-id=\"6nxjvd\" data-start=\"283\" data-end=\"305\">absorbs innovation<\/li>\n<li data-section-id=\"1dqvbai\" data-start=\"306\" data-end=\"329\">remains sustainable<\/li>\n<\/ul>\n<p data-start=\"331\" data-end=\"358\">Yet it is still fragmented.<\/p>\n<p data-start=\"360\" data-end=\"515\">Spending is not the real issue.<br data-start=\"391\" data-end=\"394\" \/>The challenge lies in ensuring uniform access, appropriateness, and quality of care across the entire national territory.<\/p>\n<p data-start=\"517\" data-end=\"588\">This is where the next phase of the system\u2019s evolution will be decided.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I Rapporti regionali 2024 AIFA offrono una lettura territoriale dell\u2019uso dei farmaci in Italia. Consumi stabili, spesa in crescita e forti differenze tra regioni delineano un sistema sotto controllo, ma ancora disomogeneo.<\/p>\n","protected":false},"author":33,"featured_media":26487,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1101,796],"tags":[],"class_list":{"0":"post-26540","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-highlights-en","8":"category-market"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medicines in Italy: the geography of Healthcare demand - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"Rapporti AIFA sull\u2019uso dei farmaci in Italia. Spesa in crescita, consumi stabili e forti differenze regionali.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicines in Italy: the geography of Healthcare demand - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"Rapporti AIFA sull\u2019uso dei farmaci in Italia. Spesa in crescita, consumi stabili e forti differenze regionali.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-28T06:59:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-05T15:14:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Cristiana Bernini\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marco Zeni\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\"},\"author\":{\"name\":\"Cristiana Bernini\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/90d788972b195d0c9518206e9fe15c08\"},\"headline\":\"Medicines in Italy: the geography of Healthcare demand\",\"datePublished\":\"2026-04-28T06:59:26+00:00\",\"dateModified\":\"2026-05-05T15:14:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\"},\"wordCount\":571,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png\",\"articleSection\":[\"HIGHLIGHTS\",\"Market\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\",\"name\":\"Medicines in Italy: the geography of Healthcare demand - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png\",\"datePublished\":\"2026-04-28T06:59:26+00:00\",\"dateModified\":\"2026-05-05T15:14:36+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/90d788972b195d0c9518206e9fe15c08\"},\"description\":\"Rapporti AIFA sull\u2019uso dei farmaci in Italia. Spesa in crescita, consumi stabili e forti differenze regionali.\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medicines in Italy: the geography of Healthcare demand\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/90d788972b195d0c9518206e9fe15c08\",\"name\":\"Cristiana Bernini\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2f72dff643e811e45f82ed89758985ef032d7e8554f8a49e99e00ff250a44397?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2f72dff643e811e45f82ed89758985ef032d7e8554f8a49e99e00ff250a44397?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2f72dff643e811e45f82ed89758985ef032d7e8554f8a49e99e00ff250a44397?s=96&d=mm&r=g\",\"caption\":\"Cristiana Bernini\"},\"url\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medicines in Italy: the geography of Healthcare demand - MakingPharmaIndustry","description":"Rapporti AIFA sull\u2019uso dei farmaci in Italia. Spesa in crescita, consumi stabili e forti differenze regionali.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/","og_locale":"en_US","og_type":"article","og_title":"Medicines in Italy: the geography of Healthcare demand - MakingPharmaIndustry","og_description":"Rapporti AIFA sull\u2019uso dei farmaci in Italia. Spesa in crescita, consumi stabili e forti differenze regionali.","og_url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2026-04-28T06:59:26+00:00","article_modified_time":"2026-05-05T15:14:36+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png","type":"image\/png"}],"author":"Cristiana Bernini","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marco Zeni","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/"},"author":{"name":"Cristiana Bernini","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/90d788972b195d0c9518206e9fe15c08"},"headline":"Medicines in Italy: the geography of Healthcare demand","datePublished":"2026-04-28T06:59:26+00:00","dateModified":"2026-05-05T15:14:36+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/"},"wordCount":571,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png","articleSection":["HIGHLIGHTS","Market"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/","url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/","name":"Medicines in Italy: the geography of Healthcare demand - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png","datePublished":"2026-04-28T06:59:26+00:00","dateModified":"2026-05-05T15:14:36+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/90d788972b195d0c9518206e9fe15c08"},"description":"Rapporti AIFA sull\u2019uso dei farmaci in Italia. Spesa in crescita, consumi stabili e forti differenze regionali.","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2026\/04\/consumo-farmaci-AIFA.png","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/market\/farmaci-in-italia-la-geografia-della-domanda-sanitaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Medicines in Italy: the geography of Healthcare demand"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/90d788972b195d0c9518206e9fe15c08","name":"Cristiana Bernini","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2f72dff643e811e45f82ed89758985ef032d7e8554f8a49e99e00ff250a44397?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2f72dff643e811e45f82ed89758985ef032d7e8554f8a49e99e00ff250a44397?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2f72dff643e811e45f82ed89758985ef032d7e8554f8a49e99e00ff250a44397?s=96&d=mm&r=g","caption":"Cristiana Bernini"},"url":""}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/26540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=26540"}],"version-history":[{"count":3,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/26540\/revisions"}],"predecessor-version":[{"id":26543,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/26540\/revisions\/26543"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/26487"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=26540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=26540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=26540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}